Penn Medicine Provider
Dermatology
Jennifer Villasenor-Park, MD, PhD
4.9
(1442)
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Perelman
View 1 additional location
Schedule onlineCall 215-504-7700

About me

  • Associate Professor of Clinical Dermatology

Education and training

  • Medical School: Harvard University
  • Residency: University of Massachusetts Medical Center
  • Residency: UPMC Presbyterian

What my patients think about me

Average Rating
4.9

1442 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

June 2025
5.0
5.0
great overall experience
June 2025
5.0
5.0
good experience!
June 2025
5.0
5.0
good physician.
June 2025
5.0
5.0
excellent doctor

Insurance accepted

My Locations

Learn about location
Learn about location

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Villasenor-Park is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Elghawy O, Yang AG, Sussman JH, Thomas CJ, Carter JS, Landsburg DJ, Svoboda J, Kim E, Rook AH, Chung J, Villasenor-Park J, Plastaras JP, LaRiviere M, Hubbeling H, Chelius M, Nasta SD, Chong EA, Schuster SJ, Barta SK. Retrospective cohort study of novel oral agents lenalidomide and duvelisib for relapsed or refractory mycosis fungoides and Sézary syndrome , J Am Acad Dermatol, 92(3): 2025,634-636

Villasenor-Park J, Chung J, Kim EJ. Cutaneous B-Cell Lymphomas , Hematol Oncol Clin North Am, 38(5): 2024,1111-1131

Jaclyn Rosenthal Himeles, Joseph Holton, Carmela Vittorio, Alain H Rook, Paul Haun, Jennifer Villasenor-Park, Sara Samimi, Ellen J Kim Recent trends in skin directed and self-administered systemic treatment costs in the United States for Cutaneous T-cell Lymphoma , J Am Acad Dermatol, 88(3): 2023,680-683

Jennifer Villasenor-Park and Ellen Kim Chapter 113: Sezary Syndrome in "Fitzpatrick's Therapeutics: A Clinician's Guide to Dermatologic Treatment , McGraw-Hill LLC: 2023,502

David M Weiner, Ashley K Clark, Rahul S Bhansali, Lisa Pappas-Taffer, Stefan K Barta, Jennifer Villasenor-Park, Paul L Haun, Carmela C Vittorio, Alain H Rook, Ellen J Kim, Sara S Samimi Usage and safety of topical tacrolimus in patients with mycosis fungoides , Clin Exp Dermatol : 2022

Ziyang Xu, Elizabeth Margolskee, Jennifer Villasenor-Park, Adam I Rubin, Michele C Khurana A healthy 16-year-old boy presenting with multifocal asymptomatic subcutaneous nodules , Pediatric Dermatology, 39(1): 2022

Daniel J Lewis, Paul L Haun, Sara S Samimi, Carmela C Vittorio, Jennifer Villasenor-Park, Stefan K Barta, Daniel J Landsburg, Jakub Svoboda, Sunita D Nasta, Stephen J Schuster, Alain H Rook, Ellen J Kim Brentuximab Vedotin for Relapsed or Refractory Sézary Syndrome , JAMA Dermatol, 157(3): 2021,317-321

Joseph S. Durgin, BA1; Neha N. Jariwala, MD1; Maria Wysocka, PhD1; Kevin K. Zhang, BS1; Amit Maity, MD, PhD2; Bernice Benoit, BS1; John P. Plastaras, MD, PHD2; Daniel J. Lewis, MD1; Jaclyn M. Rosenthal, MD1; Jessica E. Teague, PhD3; Sara Berg, MD1; Christina Del Guzzo, MD1; Ellen J. Kim, MD1; Carmela Vittorio, MD1; Paul L. Haun, MD1; Sara S. Samimi, MD1; Jennifer Villasenor-Park, MD, PHD1; Joanne Inverso, RN1; Rachael A. Clark, MD, PhD3; Alain H. Rook, MD1 Low-Dose Total Skin Electron Beam Therapy as Part of a Multimodality Regimen for Treatment of Sézary Syndrome Clinical, Immunologic, and Molecular Analysis , JAMA Dermatology: 2021

Jennifer Villasenor-Park Dermatologic Surgery in Pregnancy in "Cutaneous Disorders of Pregnancy" , Springer International Publishing: 2020,113-121

Jennifer Villasenor-Park Skin Cancer in Pregnancy in "Cutaneous Disorders of Pregnancy" , Springer International Publishing: 2020,89-111